156 related articles for article (PubMed ID: 2413370)
21. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
22. Effect of MAO inhibitors on the high-affinity reuptake of biogenic amines in rat subcortical regions.
Tekes K; Magyar K
Neurobiology (Bp); 2000; 8(3-4):257-64. PubMed ID: 11225517
[TBL] [Abstract][Full Text] [Related]
23. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
[TBL] [Abstract][Full Text] [Related]
24. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
Nguyen TV; Juorio AV; Greenshaw AJ
Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
[TBL] [Abstract][Full Text] [Related]
25. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
Youdim MB; Gross A; Finberg JP
Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700
[TBL] [Abstract][Full Text] [Related]
26. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
Finberg JP; Wang J; Goldstein DS; Kopin IJ; Bankiewicz KS
J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
Paterson IA; Juorio AV; Berry MD; Zhu MY
J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
[TBL] [Abstract][Full Text] [Related]
28. Monoamine oxidase (MAO)-A but not MAO-B inhibitors potentiate tyramine-induced catecholamine release from PC12 cells.
Youdim MB
J Neurochem; 1990 Feb; 54(2):411-4. PubMed ID: 2299343
[TBL] [Abstract][Full Text] [Related]
29. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
[TBL] [Abstract][Full Text] [Related]
30. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
Glover V; Pycock CJ; Sandler M
Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
[TBL] [Abstract][Full Text] [Related]
31. The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B.
Janssens de Varebeke P; Pauwels G; Buyse C; David-Remacle M; De Mey J; Roba J; Youdim MB
J Neurochem; 1989 Oct; 53(4):1109-16. PubMed ID: 2769256
[TBL] [Abstract][Full Text] [Related]
32. Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors.
Yu PH; Davis BA; Durden DA; Barber A; Terleckyj I; Nicklas WG; Boulton AA
J Neurochem; 1994 Feb; 62(2):697-704. PubMed ID: 8294932
[TBL] [Abstract][Full Text] [Related]
33. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
Lenzen S; Nahrstedt H; Panten U
Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain.
Paterson IA; Davis BA; Durden DA; Juorio AV; Yu PH; Ivy G; Milgram W; Mendonca A; Wu P; Boulton AA
Neurochem Res; 1995 Dec; 20(12):1503-10. PubMed ID: 8789614
[TBL] [Abstract][Full Text] [Related]
35. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
Kerecsen L; Bunag RD
J Pharmacol Exp Ther; 1989 Nov; 251(2):645-9. PubMed ID: 2509682
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition by 4,alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain.
Fagervall I; Kelder D; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):143-7. PubMed ID: 2460774
[TBL] [Abstract][Full Text] [Related]
37. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.
Celada P; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):583-90. PubMed ID: 7689703
[TBL] [Abstract][Full Text] [Related]
38. Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition.
Knoll J; Miklya I
Arch Int Pharmacodyn Ther; 1994; 328(1):1-15. PubMed ID: 7893186
[TBL] [Abstract][Full Text] [Related]
39. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
[TBL] [Abstract][Full Text] [Related]
40. Reversible, amine--selective effects of acute and chronic brofaromine treatment in the rat.
Dyck LE; Boulton AA
Life Sci; 1992; 51(1):59-66. PubMed ID: 1614274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
